June 26, 2020
Authored and Edited by Kevin J. Spinella; Kara A. Specht; Elizabeth D. Ferrill
In In re: PersonalWeb Techs., LLC, No. 2019-1918 (Fed. Cir. June 17, 2020), the Federal Circuit affirmed the district court’s ruling that a dismissal with prejudice in an earlier case against Amazon barred PersonalWeb’s later infringement actions against Amazon’s customers.
PersonalWeb asserted five patents against multiple Amazon customers in the EDTX. Amazon intervened, undertaking the defense of its customers. It pursued a declaratory judgment against PersonalWeb to bar the current action based on a prior litigation against Amazon asserting the same patents and accusing the same technology, which was dismissed with prejudice following a stipulation. Amazon moved for summary judgement, and it was granted in part, holding that PersonalWeb’s claims against Amazon’s customers were barred by claim preclusion.
PersonalWeb appealed, first arguing that the prior action was different because it accused a different feature of the accused technology. The Federal Circuit disagreed because the overall system was the same and the purportedly newly accused feature was acknowledged in the infringement contentions of the earlier case. PersonalWeb next challenged the dismissal under the Kessler doctrine, arguing that because “no issues” were litigated before dismissal, the Kessler doctrine is not appropriate, and Amazon cannot be an “adjudged non-infringer.” The Federal Circuit again disagreed holding that litigation is not a prerequisite to the Kessler doctrine.
Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.